Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
EXELIXIS, INC. (EXEL)
Smith Julie — Director
Shares
44,087
Price
$44.50
Total Value
$1.96M
Shares Held After
20,590
% of Holdings
68.2%
Geron Corporation (GERN)
ROBERTSON MICHELLE — EVP, CHIEF FINANCIAL OFFICER
Shares
9,855
Price
$1.94
Total Value
$19.12K
Shares Held After
17,645
% of Holdings
35.8%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
3,081
Price
$69.36
Total Value
$213.70K
Shares Held After
108,231
% of Holdings
2.8%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
3,684
Price
$65.89
Total Value
$242.73K
Shares Held After
71,343
% of Holdings
4.9%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
3,397
Price
$65.01
Total Value
$220.84K
Shares Held After
75,027
% of Holdings
4.3%
Immunocore Holdings plc (IMCR)
Berman David M — HEAD OF R&D
Shares
5,965
Price
$32.35
Total Value
$192.97K
Shares Held After
5,859
% of Holdings
50.4%
Immunocore Holdings plc (IMCR)
St Leger Tina Amber — CHIEF HR OFFICER
Shares
1,000
Price
$32.35
Total Value
$32.35K
Shares Held After
1,119
% of Holdings
47.2%
Immunocore Holdings plc (IMCR)
GOLL JOHN — SVP, FINANCE & CAO
Shares
698
Price
$32.35
Total Value
$22.58K
Shares Held After
653
% of Holdings
51.7%
Immunocore Holdings plc (IMCR)
Jallal Bahija — Director
Shares
11,474
Price
$32.35
Total Value
$371.18K
Shares Held After
12,343
% of Holdings
48.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
368
Price
$473.68
Total Value
$174.31K
Shares Held After
48,650
% of Holdings
0.8%
Precision BioSciences, Inc. (DTIL)
SMITH J. JEFFERSON — Chief Research Officer
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
121,926
% of Holdings
3.9%
Precision BioSciences, Inc. (DTIL)
Amoroso Michael — Director
Shares
20,559
Price
$3.84
Total Value
$78.95K
Shares Held After
243,392
% of Holdings
7.8%
Precision BioSciences, Inc. (DTIL)
Scimeca Dario — General Counsel and Secretary
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
56,457
% of Holdings
8.0%
Precision BioSciences, Inc. (DTIL)
Kelly John Alexander — Chief Financial Officer
Shares
8,149
Price
$3.84
Total Value
$31.29K
Shares Held After
125,883
% of Holdings
6.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
638
Price
$473.68
Total Value
$302.21K
Shares Held After
7,750
% of Holdings
7.6%
Seer, Inc. (SEER)
Farokhzad Omid — Director
Shares
24,385
Price
$1.99
Total Value
$48.65K
Shares Held After
3,349,064
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
817
Price
$473.68
Total Value
$387.00K
Shares Held After
20,727
% of Holdings
3.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
1,244
Price
$473.68
Total Value
$589.26K
Shares Held After
15,748
% of Holdings
7.3%
Seer, Inc. (SEER)
Horn David R. — PRESIDENT & CFO
Shares
7,743
Price
$1.99
Total Value
$15.45K
Shares Held After
501,262
% of Holdings
1.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
1,182
Price
$473.68
Total Value
$559.89K
Shares Held After
8,486
% of Holdings
12.2%
Solid Biosciences Inc. (SLDB)
Cumbo Alexander — Director
Shares
16,644
Price
$5.82
Total Value
$96.92K
Shares Held After
235,405
% of Holdings
6.6%
Solid Biosciences Inc. (SLDB)
Brooks Gabriel — Chief Medical Officer
Shares
0
Price
$5.82
Total Value
$0.00
Shares Held After
89,466
% of Holdings
0.0%
Solid Biosciences Inc. (SLDB)
Tan Kevin — CFO & Treasurer
Shares
5,404
Price
$5.82
Total Value
$31.47K
Shares Held After
99,422
% of Holdings
5.2%
Solid Biosciences Inc. (SLDB)
Howton David T — Chief Operating Officer
Shares
7,469
Price
$5.82
Total Value
$43.49K
Shares Held After
105,077
% of Holdings
6.6%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
2,658
Price
$5.82
Total Value
$15.48K
Shares Held After
27,474
% of Holdings
8.8%
Solid Biosciences Inc. (SLDB)
Herzich Paul — Chief Technology Officer
Shares
3,616
Price
$5.82
Total Value
$21.06K
Shares Held After
72,638
% of Holdings
4.7%
Solid Biosciences Inc. (SLDB)
Hanrahan Jessie — Chief Regulatory Officer
Shares
4,134
Price
$5.82
Total Value
$24.07K
Shares Held After
74,318
% of Holdings
5.3%
Adagio Therapeutics, Inc. (ADGI)
Andersen Jill — Chief Legal Officer, Secretary
Shares
34,939
Price
$1.58
Total Value
$55.13K
Shares Held After
181,736
% of Holdings
16.1%
Adagio Therapeutics, Inc. (ADGI)
Lee Timothy Edward — Chief Commercial Officer
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
117,717
% of Holdings
15.1%
EXELIXIS, INC. (EXEL)
Hefti Brenda — SVP and General Counsel
Shares
18,669
Price
$44.01
Total Value
$821.62K
Shares Held After
96,512
% of Holdings
16.2%
Adagio Therapeutics, Inc. (ADGI)
Duke William E. — Chief Financial Officer
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%
Adagio Therapeutics, Inc. (ADGI)
Green Julie — Chief Human Resources Officer
Shares
20,964
Price
$1.58
Total Value
$33.08K
Shares Held After
107,717
% of Holdings
16.3%
Adagio Therapeutics, Inc. (ADGI)
Allen Robert D. III — Chief Scientific Officer
Shares
19,392
Price
$1.58
Total Value
$30.60K
Shares Held After
114,487
% of Holdings
14.5%
Avista Public Acquisition Corp. II (AHPA)
Berkman Charles S — Chief Legal Officer
Shares
9,673
Price
$1.71
Total Value
$16.54K
Shares Held After
392,700
% of Holdings
2.4%
Avista Public Acquisition Corp. II (AHPA)
FOEHR MATTHEW W — Director
Shares
30,843
Price
$1.71
Total Value
$52.74K
Shares Held After
4,403,277
% of Holdings
0.7%
Avista Public Acquisition Corp. II (AHPA)
GUSTAFSON KURT A — Executive VP, Finance and CFO
Shares
9,301
Price
$1.71
Total Value
$15.90K
Shares Held After
268,851
% of Holdings
3.3%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
133,688
Price
$1.32
Total Value
$176.47K
Shares Held After
1,654,186
% of Holdings
8.1%
Dermata Therapeutics, Inc. (DRMA)
Bedoya-Toro Munera Maria E — SVP, Regulatory Affairs
Shares
1,000
Price
$1.27
Total Value
$1.27K
Shares Held After
1,012
% of Holdings
98.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
200
Price
$103.84
Total Value
$20.77K
Shares Held After
114,897
% of Holdings
0.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,069
Price
$103.00
Total Value
$110.11K
Shares Held After
115,097
% of Holdings
0.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
900
Price
$101.70
Total Value
$91.53K
Shares Held After
116,166
% of Holdings
0.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
200
Price
$100.52
Total Value
$20.10K
Shares Held After
117,066
% of Holdings
0.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,200
Price
$99.42
Total Value
$119.30K
Shares Held After
117,266
% of Holdings
1.0%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
2,200
Price
$29.59
Total Value
$65.11K
Shares Held After
387,075
% of Holdings
0.6%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
5,400
Price
$28.95
Total Value
$156.33K
Shares Held After
389,275
% of Holdings
1.4%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
900
Price
$28.02
Total Value
$25.22K
Shares Held After
394,675
% of Holdings
0.2%
EXELIXIS, INC. (EXEL)
Smith Julie — Director
Shares
42,422
Price
$43.33
Total Value
$1.84M
Shares Held After
20,590
% of Holdings
67.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
45,000
Price
$26.17
Total Value
$1.18M
Shares Held After
25,000
% of Holdings
64.3%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
1,230
Price
$26.18
Total Value
$32.20K
Shares Held After
22,647
% of Holdings
5.2%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2
Price
$70.13
Total Value
$140.26
Shares Held After
111,312
% of Holdings
0.0%
Showing 351–400 of 936 transactions (page 8 of 19)